In the present study, we systematically compared the imaging ability of PSP1 with that of annexin V in terms of PS binding kinetics, apoptotic cell-targeting ability, and the efficacy of homing to apoptotic tumor cells after cancer therapy. This evidence concerns the gene ANXA5 and neoplasm.